The WKT-C1 "Smart" Karl Fischer moisture analyzer is a fully automatic moisture analysis system jointly developed by VicoMeter's R&D department and the 53rd Research Institute of China North Industries Group. Using the volumetric principle, it measures moisture down to 10 ppm and determines solids, liquids, and powders within 30 seconds. Its RS232 port connects printers, balances, computers, and other peripherals; it stores 100 data sets; and its separate 7-inch capacitive touchscreen runs an embedded micro Windows system — powerful, with clear operation prompts and flexible user interaction. In 2010, with help on ultra-precision displacement measurement from the State Key Laboratory of Precision Measurement Technology and Instruments at Tsinghua University, the WKT-C1 titration system was further improved, raising its measurement accuracy once again. The WKT-C1 complies with multiple national and international moisture standards and with pharmacopoeia requirements and is widely used in chemicals, petroleum, pharmaceuticals, power, food, batteries, plastics, research, and testing.

Nanjing Haijing Pharmaceutical Co., Ltd., formerly Nanjing Cod Liver Oil Factory — one of the three earliest cod liver oil factories in China — is a technology-innovation enterprise integrating pharmaceutical R&D, production, and sales.

Located in the Nanjing High-Tech Development Zone of Jiangsu Province, the company operates five production lines for soft capsules, oral solutions, emulsions, syrups, and sprays, all of which have passed the 2014 revised GMP certification.

The company mainly produces vitamins and pediatric oral liquid preparations. With a sound quality management and innovation system, the company has made its operations scientific, standardized, and efficient. It has established a development strategy centered on customers and patients, guided by the market, focused on superior products, and aimed at efficiency and scale.

Relying on Aige Bio's strong research capabilities and fruitful achievements, the company has initiated more than a dozen new pediatric oral liquid drug projects that are marketed abroad but not yet available in China, which will be launched successively in the coming years. The company also owns a series of achievements, including Class I new drugs with independent intellectual property rights, laying the foundation for Haijing's long-term development.

Upholding a corporate culture in which technology creates the future and learning leads development, and adhering to the philosophy that products begin with design, the company develops and promotes precise, safe, and effective high-quality medicines to safeguard the health of Chinese children.